Diabetes Education for Type 2 Diabetes
Trial Summary
What is the purpose of this trial?
Health disparities in the Republic of the Marshall Islands are striking, with extremely high rates of type 2 diabetes. Documented prevalence of type 2 diabetes in the Marshall Islands ranges from 20%-50%.This is significantly higher than the global (8.5%) and United States (11%) prevalence. Diabetes doubles the risk of heart disease; is the leading cause of kidney failure, lower limb amputation, and acquired blindness; and reduces life expectancy by as much as 15 years. Diabetes self-management education and support is critical for persons with diabetes. This study aims to conduct a cluster-randomized controlled trial using a wait-list control to evaluate the effectiveness of family model diabetes self-management education and support when delivered in faith-based organizations (i.e., churches) in Marshallese by trained community health workers. The study will be conducted with up to 288 participants with type 2 diabetes and up to 288 of their family members. The primary study outcome will be glycemic control as measured by HbA1c. Secondary biometric measures include: fasting glucose, weight, body mass index, and blood pressure. Survey data will be collected pre-intervention, immediately post-intervention, four months post-intervention, and 12 months post-intervention for the intervention arm of the study. The control arm of the study will have two pre-intervention data collections before beginning the intervention. Data will then be collected from the control group immediately post-intervention, four months post-intervention, and 12 months post intervention.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on diabetes education and support, so it's likely you can continue your current treatment, but you should confirm with the trial organizers.
What data supports the effectiveness of the treatment Family Model Diabetes Self-Management Education and Support for Type 2 Diabetes?
Is the Family Model Diabetes Self-Management Education and Support safe for humans?
How is the Family Model DSME treatment different from other treatments for type 2 diabetes?
Eligibility Criteria
This trial is for Marshallese adults with type 2 diabetes who have an HbA1c level of at least 6.5% and a family member to join them in the study. They shouldn't plan to move away, have conditions preventing protocol adherence, severe disabilities, or prior diabetes education within five years.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Intervention
Survey data collected pre-intervention for both intervention and control groups
Intervention
Family model diabetes self-management education and support delivered in faith-based organizations
Post-Intervention Follow-up
Survey data collected immediately post-intervention, 4 months post-intervention, and 12 months post-intervention
Treatment Details
Interventions
- Family Model Diabetes Self-Management Education and Support (Behavioral Intervention)
- Family Model Diabetes Self-Management Education and Support (Wait-list) (Behavioral Intervention)